A novel cholesterol absorption inhibitor, ezetimibe, decreases adipose-derived and vascular PAI-1 expression in vivo.
Yamamoto
Koji
K
Shibayama
Shuji
S
Takeshita
Kyosuke
K
Kojima
Tetsuhito
T
Takamatsu
Junki
J
D000273:Adipose Tissue / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001384:Azetidines / Q000494:pharmacology*; D000069438:Ezetimibe; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D017395:Plasminogen Activator Inhibitor 1 / Q000096:biosynthesis*
D000924:Anticholesteremic Agents; D001384:Azetidines; D017395:Plasminogen Activator Inhibitor 1; D000069438:Ezetimibe